Household Transmission and Symptomology of Severe Acute Respiratory Syndrome Coronavirus 2 Alpha Variant among Children-California and Colorado, 2021.


Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
08 2022
Historique:
received: 02 02 2022
revised: 30 03 2022
accepted: 15 04 2022
pubmed: 22 4 2022
medline: 9 9 2022
entrez: 21 4 2022
Statut: ppublish

Résumé

To assess the household secondary infection risk (SIR) of B.1.1.7 (Alpha) and non-Alpha lineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among children. During January to April 2021, we prospectively followed households with a SARS-CoV-2 infection. We collected questionnaires, serial nasopharyngeal swabs for reverse transcription polymerase chain reaction testing and whole genome sequencing, and serial blood samples for serology testing. We calculated SIRs by primary case age (pediatric vs adult), household contact age, and viral lineage. We evaluated risk factors associated with transmission and described symptom profiles among children. Among 36 households with pediatric primary cases, 21 (58%) had secondary infections. Among 91 households with adult primary cases, 51 (56%) had secondary infections. SIRs among pediatric and adult primary cases were 45% and 54%, respectively (OR, 0.79; 95% CI, 0.41-1.54). SIRs among pediatric primary cases with Alpha and non-Alpha lineage were 55% and 46%, respectively (OR, 1.52; 95% CI, 0.51-4.53). SIRs among pediatric and adult household contacts were 55% and 49%, respectively (OR, 1.01; 95% CI, 0.68-1.50). Among pediatric contacts, no significant differences in the odds of acquiring infection by demographic or household characteristics were observed. Household transmission of SARS-CoV-2 from children and adult primary cases to household members was frequent. The risk of secondary infection was similar among child and adult household contacts. Among children, household transmission of SARS-CoV-2 and the risk of secondary infection was not influenced by lineage. Continued mitigation strategies (eg, masking, physical distancing, vaccination) are needed to protect at-risk groups regardless of virus lineage circulating in communities.

Identifiants

pubmed: 35447121
pii: S0022-3476(22)00338-9
doi: 10.1016/j.jpeds.2022.04.032
pmc: PMC9015725
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-37.e7

Investigateurs

Alexis Alford (A)
Samuel Baird (S)
Laura Bankers (L)
Jazmin Bello (J)
Shanna Bolcen (S)
Peter Browning (P)
Peter W Cook (PW)
Ebenezer David (E)
Jennifer L Harcourt (JL)
Geir Hareland (G)
Molly C Hetherington-Rauth (MC)
Diana Ir (D)
Shilpi Jain (S)
Tao Lily Jia (TL)
Ralen Johnson (R)
Anna Kelleher (A)
Gimin Kim (G)
Yan Li (Y)
Brian Lynch (B)
Daniel Mallal (D)
Panagiotis Maniatis (P)
Rachel Marine (R)
Magdalena Medrzycki (M)
John M Metz (JM)
Anna Maria Montmayeur (AM)
Kimberly M Moss (KM)
Han Jia Justin Ng (HJ)
Van Nyugen (V)
Kristina Ortiz (K)
Clinton R Paden (CR)
So Hee Park (SH)
Krista Queen (K)
Alexandria E B Rossheim (AEB)
Vera Semenova (V)
Samuel S Shepard (SS)
Azaibi Tamin (A)
Ying Tao (Y)
Alexandra Tejada-Strop (A)
Phili Wong (P)
Briana Zellner (B)
Jing Zhang (J)

Informations de copyright

Published by Elsevier Inc.

Auteurs

Michelle A Waltenburg (MA)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: nvr6@cdc.gov.

Melissa J Whaley (MJ)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

Rebecca J Chancey (RJ)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

Marisa A P Donnelly (MAP)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA.

Meagan R Chuey (MR)

Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA; County of San Diego Health and Human Services Agency, San Diego, CA.

Raymond Soto (R)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA.

Noah G Schwartz (NG)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA.

Victoria T Chu (VT)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA.

Sadia Sleweon (S)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

David W McCormick (DW)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA.

Anna Uehara (A)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

Adam C Retchless (AC)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

Suxiang Tong (S)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

Jennifer M Folster (JM)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

Marla Petway (M)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

Natalie J Thornburg (NJ)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

Jan Drobeniuc (J)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

Brett Austin (B)

County of San Diego Health and Human Services Agency, San Diego, CA.

Meghan M Hudziec (MM)

Colorado Department of Public Health and Environment, Denver, CO.

Ginger Stringer (G)

Colorado Department of Public Health and Environment, Denver, CO.

Bernadette A Albanese (BA)

Tri-County Health Department, Greenwood Village, CO.

Sarah E Totten (SE)

Colorado Department of Public Health and Environment, Denver, CO.

Shannon R Matzinger (SR)

Colorado Department of Public Health and Environment, Denver, CO.

J Erin Staples (JE)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

Marie E Killerby (ME)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

Laura J Hughes (LJ)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

Almea Matanock (A)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

Mark Beatty (M)

County of San Diego Health and Human Services Agency, San Diego, CA.

Jacqueline E Tate (JE)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

Hannah L Kirking (HL)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

Christopher H Hsu (CH)

Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH